Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 2

Therapeutics and Clinical Risk Management


Archive: Volume 2, 2006


Cost-benefit analysis of influenza vaccination in a public healthcare unit

Giorgio L Colombo, Antonio Ferro, Marta Vinci, Maria Zordan, Giulio Serra

Therapeutics and Clinical Risk Management 2006, 2:219-226

Published Date: 15 June 2006

Treatment of pruritic diseases with topical calcineurin inhibitors

Sonja Ständer, Funda Schürmeyer-Horst, Thomas A Luger, Elke Weisshaar

Therapeutics and Clinical Risk Management 2006, 2:213-218

Published Date: 15 June 2006

Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia

Isabelle Wauters, Karin Pat, Johan Vansteenkiste

Therapeutics and Clinical Risk Management 2006, 2:175-186

Published Date: 15 June 2006

Oral mucositis induced by anticancer treatments: physiopathology and treatments

D’Hondt, Lionel, Lonchay, Christophe, André, Marc, Canon, Jean-Luc

Therapeutics and Clinical Risk Management 2006, 2:159-168

Published Date: 15 June 2006

Voriconazole in the management of nosocomial invasive fungal infections

Javier Pemán, Miguel Salavert, Emilia Cantón, Isidro Jarque, Eva Romá, et al

Therapeutics and Clinical Risk Management 2006, 2:129-158

Published Date: 15 June 2006

Editorial ||FREE PAPER||

Garry Walsh

Therapeutics and Clinical Risk Management 2006, 2:127-128

Published Date: 15 June 2006